To the Editor Ding et al address an important problem: whether inherited susceptibility changes the age at which modifiable factors identify excess pancreatic cancer risk. In their UK Biobank analysis, the modifiable risk score (MRS) had its strongest association before age 60 years, a finding the authors interpret as support for prevention earlier in life, especially among people at high genetic risk for pancreatic cancer.